Skip to content 
DECODE-PD isn’t just about advancing treatment—we’re also chasing prevention. Research shows that prevention is key in Parkinson’s disease. Treating is progress, but stopping it before it starts? That’s a game-changer.
For the studies below, our aim is to recruit those individuals that do not have a Parkinson’s disease diagnosis.
NADage
The NADage study aims to investigate the potential of nicotinamide riboside (NR) in reducing physical and cognitive decline in the frail population, while improving clinical symptoms of frailty.
NOR-RBD
NOR-RBD is the world’s first preventive trials in Parkinson’s disease and will recruit individuals in the prodromal phase, identified via REM sleep behavior disorder (RBD).
NADream
NADream aims to investigate the effects of NR on sleep quality in healthy adults. The hypothesis is that NR may improve the brain’s ability to “rest” during sleep, which may result in better sleep quality.
